Forbes August 8, 2024
Bruce Japsen

A big California health insurer that grabbed headlines a year ago for its effort to “rip up the playbook on drug pricing,” may launch with Mark Cuban’s Cost Plus Drugs in a different role than originally billed.

The role of Mark Cuban Cost Plus Drug Company has changed a year after Blue Shield of California a year ago announced the prescription management model that also includes Amazon, a pharmacy benefit venture owned by Blue Cross and Blue Shield plans called Prime Therapeutics, and Abarca Health, a pharmacy benefit and services firm.

A year ago, Blue Shield of California said Mark Cuban Cost Plus Drug Company will “establish a simple, transparent, and more affordable pricing model, reducing surprise drug costs at...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
Achieving Value-Based Care Through the Payvider Model
10 recent healthcare industry lawsuits, settlements - 7
STAT+: UnitedHealth pays its own physician groups considerably more than others, driving up consumer costs and its profits
AI could be ‘transformational’ for payers, experts say
Reforming HSAs To Expand Gig Workers’ Access To Affordable Health Care

Share This Article